WHO Estimates 10 Percent of Developing Countries' Medical Products Falsified or Substandard

"Substandard and falsified medicines particularly affect the most vulnerable communities," said Dr. Tedros Adhanom Ghebreyesus, WHO's director-general. "Imagine a mother who gives up food or other basic needs to pay for her child's treatment, unaware that the medicines are substandard or falsified, and then that treatment causes her child to die. This is unacceptable. Countries have agreed on measures at the global level – it is time to translate them into tangible action."

Newly available research from the World Health Organization indicates 10 percent of the medical products available in low- and middle-income countries are substandard or falsified. WHO announced the findings Nov. 28 and urged governments to take action.

As a result, people in those countries are taking medicines that fail to treat or prevent disease. This wastes the money of individuals and health systems that purchase these products, and the deficient medical products also can cause serious illness or death.

"Substandard and falsified medicines particularly affect the most vulnerable communities," said Dr. Tedros Adhanom Ghebreyesus, WHO's director-general. "Imagine a mother who gives up food or other basic needs to pay for her child's treatment, unaware that the medicines are substandard or falsified, and then that treatment causes her child to die. This is unacceptable. Countries have agreed on measures at the global level – it is time to translate them into tangible action."

Since 2013, WHO reported, it has received 1,500 reports of cases of substandard or falsified products. Of these, antimalarials and antibiotics are the most commonly reported. The largest number of reports (42 percent) came from the WHO African Region, while 21 percent came from the WHO Region of the Americas and 21 percent from the WHO European Region. WHO argues this is probably a small fraction of the total problem, and many cases may be going unreported in other regions.

"Many of these products, like antibiotics, are vital for people's survival and well-being," said Dr. Mariângela Simão, WHO assistant director-general for Access to Medicines, Vaccines and Pharmaceuticals. "Substandard or falsified medicines not only have a tragic impact on individual patients and their families, but also are a threat to antimicrobial resistance, adding to the worrying trend of medicines losing their power to treat."

Until 2013, there was no global reporting of this information. WHO in July 2013 established a global surveillance system for substandard and falsified products, and now many countries are active in reporting suspicious medicines, vaccines, and medical devices. WHO by now has trained 550 regulators from 141 countries to detect and respond to this issue. As more people are trained, more cases are reported to WHO.

Product Showcase

  • Magid® D-ROC® GPD412 21G Ultra-Thin Polyurethane Palm Coated Work Gloves

    Magid’s 21G line is more than just a 21-gauge glove, it’s a revolutionary knitting technology paired with an advanced selection of innovative fibers to create the ultimate in lightweight cut protection. The latest offering in our 21G line provides ANSI A4 cut resistance with unparalleled dexterity and extreme comfort that no other 21-gauge glove on the market can offer! Read More

  • Full Line of Defense Against Combustible Dust Nilfisk

    Nilfisk provides a comprehensive range of industrial vacuums meticulously crafted to adhere to NFPA 652 housekeeping standards, essential for gathering combustible dust in Class I, Group D, and Class II, Groups E, F & G environments or non-classified settings. Our pneumatic vacuums are meticulously engineered to fulfill safety criteria for deployment in hazardous surroundings. Leveraging advanced filtration technology, Nilfisk ensures the secure capture of combustible materials scattered throughout your facility, ranging from fuels, solvents, and metal dust to flour, sugar, and pharmaceutical powders. Read More

  • AirChek Connect Sampling Pump

    Stay connected to your sampling with the SKC AirChek® Connect Sampling Pump! With its Bluetooth connection to PC and mobile devices, you can monitor AirChek Connect pump operation without disrupting workflow. SKC designed AirChek Connect specifically for all OEHS professionals to ensure accurate, reliable flows from 5 to 5000 ml/min and extreme ease of use. AirChek Connect offers easy touch screen operation and flexibility. It is quality built to serve you and the workers you protect. Ask about special pricing and a demo at AIHA Connect Booth 1003. Read More

Featured